ResearcherShanghai Jiao Tong UniversityNo recent work listed
Yu-Tang Gao
Matched on OpenAlex author ID A5107841198. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 21
2012: 1 paper · 2013: 2 papers · 2014: 2 papers · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper
Papers 8
- Aspirin Use and Reduced Risk of Pancreatic Cancer. Last author DOI 10.1158/1055-9965.epi-16-0508↗
- Serum B6 vitamers (pyridoxal 5'-phosphate, pyridoxal, and 4-pyridoxic acid) and pancreatic cancer risk: two nested case-control studies in Asian populations. Co-author DOI 10.1007/s10552-016-0822-6↗
- Plasma metabolite biomarkers for the detection of pancreatic cancer. Co-author DOI 10.1021/pr501135f↗
- Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, China. Co-author DOI 10.1016/j.canlet.2014.01.004↗
- Re-evaluation of ABO gene polymorphisms detected in a genome-wide association study and risk of pancreatic ductal adenocarcinoma in a Chinese population. Last author DOI 10.5732/cjc.013.10060↗
- ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis. Co-author DOI 10.1093/aje/kws458↗
- Dietary energy density is positively associated with risk of pancreatic cancer in urban Shanghai Chinese. Last author DOI 10.3945/jn.113.178129↗
- Green tea drinking and risk of pancreatic cancer: a large-scale, population-based case-control study in urban Shanghai. Last author DOI 10.1016/j.canep.2012.08.004↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Herbert Yu · 6 shared papers, 2012–2017 · strength 0.28
- Paper Aspirin Use and Reduced Risk of Pancreatic Cancer. DOI 10.1158/1055-9965.epi-16-0508↗
- Paper Plasma metabolite biomarkers for the detection of pancreatic cancer. DOI 10.1021/pr501135f↗
- Paper Re-evaluation of ABO gene polymorphisms detected in a genome-wide association study and risk of pancreatic ductal adeno… DOI 10.5732/cjc.013.10060↗
- Harvey A. Risch · 6 shared papers, 2012–2017 · strength 0.28
- Paper Aspirin Use and Reduced Risk of Pancreatic Cancer. DOI 10.1158/1055-9965.epi-16-0508↗
- Paper Plasma metabolite biomarkers for the detection of pancreatic cancer. DOI 10.1021/pr501135f↗
- Paper Re-evaluation of ABO gene polymorphisms detected in a genome-wide association study and risk of pancreatic ductal adeno… DOI 10.5732/cjc.013.10060↗
- Quanxing Ni · 3 shared papers, 2013–2017 · strength 0.16
- Paper Aspirin Use and Reduced Risk of Pancreatic Cancer. DOI 10.1158/1055-9965.epi-16-0508↗
- Paper Plasma metabolite biomarkers for the detection of pancreatic cancer. DOI 10.1021/pr501135f↗
- Paper ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis. DOI 10.1093/aje/kws458↗
- Lingeng Lu · 3 shared papers, 2013–2017 · strength 0.16
- Paper Aspirin Use and Reduced Risk of Pancreatic Cancer. DOI 10.1158/1055-9965.epi-16-0508↗
- Paper Plasma metabolite biomarkers for the detection of pancreatic cancer. DOI 10.1021/pr501135f↗
- Paper ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis. DOI 10.1093/aje/kws458↗
- Jing Wang · 2 shared papers, 2013–2014 · strength 0.09
- Samantha A. Streicher · 1 shared paper, 2017 · strength 0.07
- Mark S. Kidd · 1 shared paper, 2017 · strength 0.07
- Jian‐Min Yuan · 1 shared paper, 2016 · strength 0.06
- Joyce Yongxu Huang · 1 shared paper, 2016 · strength 0.06
- Guoxiang Xie · 1 shared paper, 2015 · strength 0.05
- Wei Ping Jia · 1 shared paper, 2015 · strength 0.05
- Hongli Xu · 1 shared paper, 2014 · strength 0.04
- Jin Xu · 1 shared paper, 2014 · strength 0.04
- Min Li · 1 shared paper, 2014 · strength 0.04
- Liang Liu · 1 shared paper, 2014 · strength 0.04
- Meng Guo · 1 shared paper, 2014 · strength 0.04
- Jiang Long · 1 shared paper, 2014 · strength 0.04
- Xianjun Yu · 1 shared paper, 2014 · strength 0.04
- Chen Liu · 1 shared paper, 2014 · strength 0.04
- Guopei Luo · 1 shared paper, 2014 · strength 0.04
- Jing Wang · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.